HYCOR Biomedical Relocates HQ to Central Indiana
04/27/2011
"Given Indiana's central location, the exceptional life sciences talent based here, as well as the economic incentives being offered by the state, we believe this is the ideal time for HYCOR to relocate as our business continues to grow," said Richard Aderman, president and CEO of HYCOR.
The Indiana Economic Development Corporation offered HYCOR up to $640,000 in performance-based tax credits based on the company's job creation plans.
HYCOR is currently leasing space in Indianapolis before selecting a permanent central Indiana location.
The company produces urinalysis and allergy and autoimmune testing products used in labs, hospitals, and doctor's offices.
Most Read
-
-
How Is the Pandemic Affecting Location Decisions in the Food & Beverage Industry?
Q2 2020
-
COVID-19 Will Remake How We Work and Live
Q2 2020
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
A “Now, Next, Later” Approach for Dealing with Pandemic Challenges
Q2 2020
-
“Future-Proofing” Corporate Location Decisions in Uncertain Times
Q2 2020
-
The Future of Manufacturing Site Selection is Connected
Q2 2020